Belimumab ameliorates symptoms and disease activity in dermatomyositis and juvenile dermatomyositis patients refractory to standard therapy: a retrospective observational study

Published: 25 April 2024| Version 1 | DOI: 10.17632/hb9gsx888b.1
Contributor:
Yu Liu

Description

Supplemental materials for paper "Belimumab ameliorates symptoms and disease activity in dermatomyositis and juvenile dermatomyositis patients refractory to standard therapy: a retrospective observational study", including detailed methods, supplemental tables and figures, and supplemental figure legends.

Files

Institutions

Central South University, Second Xiangya Hospital Department of Dermatology

Categories

Dermatomyositis, Biological Treatment

Licence